02/16/2026
PTSD hasn’t seen a new FDA-approved medication in over 20 years. But real-world data from 8,136 patients tells a different story. Ketamine infusion therapy was associated with rapid, clinically meaningful reductions in PTSD symptoms, with most gains occurring in the first few treatments. This isn’t hype. It’s outcomes—measured, modeled, and observed in everyday clinical practice.
📊 Data presented at ASKP3 using de-identified Osmind EHR outcomes. Observational data.
*Not a randomized controlled trial.